{
  "chapter": "Guillain-Barre Syndrome and Other Immune-mediat",
  "questions": [
    {
      "q_no": 1,
      "question": "Question 1: Which of the following is the most common antecedent infectious cause of Guillain-Barre \nsyndrome?",
      "options": {
        "a": "Cytomegalovirus",
        "b": "Mycoplasma pneumoniae",
        "c": "Campylobacter jejuni",
        "d": "Epstein Barr virus"
      },
      "correct_answer": "c",
      "explanation": "Campylobacter jejuni is one of the most common risk factors for GBS. Infections that may trigger GBS are: • Campylobacter jejuni • Cytomegalovirus (CMV) • Epstein Barr virus • Mycoplasma • Varicella zoster virus • Human immunodeficiency virus (HIV), dengue, or influenza, Zika, hepatitis Less commonly vaccinations, surgical procedures, and trauma have been reported to trigger the \ndevelopment of GBS.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Guillain-Barre Syndrome and Other Immune-mediat"
    },
    {
      "q_no": 2,
      "question": "Question 2: Which of the following autoantibody isotype is involved in the pathogenesis of Guillian-Barre \nsyndrome?",
      "options": {
        "a": "IgA",
        "b": "IgG",
        "c": "IgM",
        "d": "IgE"
      },
      "correct_answer": "b",
      "explanation": "IgG isotype of autoantibody is involved in the pathogenesis of GBS. IgM isotype autoantibodies are known to play a role in some types of chronic immune \nneuropathies.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Guillain-Barre Syndrome and Other Immune-mediat"
    },
    {
      "q_no": 3,
      "question": "Question 3: In Guillain-Barre syndrome due to antecedent infection with Campylobacter jejuni, the \nautoantibodies are most commonly directed against which of the following?",
      "options": {
        "a": "GM1",
        "b": "GD1a",
        "c": "GD1b",
        "d": "GalNac-GD1a"
      },
      "correct_answer": "a",
      "explanation": "Autoantibodies in GBS due to Campylobacter jejuni infection are directed most commonly against \nGM1 gangliosidase.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Guillain-Barre Syndrome and Other Immune-mediat"
    },
    {
      "q_no": 4,
      "question": "Question 4: Which of the following is the most common type of Guillian-Barre syndrome? 1142 \nSold by @itachibot",
      "options": {
        "a": "Acute motor axonal neuropathy",
        "b": "Acute inflammatory demyelinating polyneuropathy",
        "c": "Acute motor sensory axonal neuropathy",
        "d": "Miller Fisher syndrome"
      },
      "correct_answer": "b",
      "explanation": "Acute inflammatory demyelinating polyneuropathy (AIDP) is the most common type of GBS. There are several types of Guillain–Barre syndrome, which are recognized by electrodiagnostic \nstudies and pathological distinctions. These include: A. Demyelinating • Acute inflammatory demyelinating polyneuropathy (AIDP) - most common B. Axonal • Acute motor axonal neuropathy (AMAN) • Acute motor–sensory axonal neuropathy (AMSAN) C. Regional GBS syndromes • Miller–Fisher syndrome (MFS) 1149 \nSold by @itachibot • Pure sensory forms • Ophthalmoplegia with anti-GQ1b antibodies as part of severe motor-sensory GBS • GBS with severe bulbar and facial paralysis • Acute pandysautonomia",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Guillain-Barre Syndrome and Other Immune-mediat"
    },
    {
      "q_no": 5,
      "question": "Question 5: Which type of Guillain-Barre syndrome most commonly affects patients in the pediatric age \ngroup?",
      "options": {
        "a": "Acute motor axonal neuropathy",
        "b": "Acute inflammatory demyelinating polyneuropathy",
        "c": "Acute motor sensory axonal neuropathy",
        "d": "Miller Fisher syndrome"
      },
      "correct_answer": "a",
      "explanation": "The acute motor axonal neuropathy (AMAN) subtype of Guillain-Barre syndrome (GBS) is more \ncommon in pediatric age groups. Type \nAge group affected Acute inflammatory demyeli \nnating polyneuropathy (AIDP) Adults Acute motor axonal neuropat \nhy (AMAN) ChildrenYoung adu \nlts Acute motor-sensory axonal \nneuropathy (AMSAN) Mostly adults Miller–Fisher syndrome \nAdultsChildren",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Guillain-Barre Syndrome and Other Immune-mediat"
    },
    {
      "q_no": 6,
      "question": "Question 6: Acute inflammatory demyelinating polyneuropathy differs from acute motor axonal \nneuropathy, in that, in the latter, the complement deposition along with IgG antibodies \noccurs at:",
      "options": {
        "a": "Nodes of Ranvier",
        "b": "Neuromuscular junction",
        "c": "Oligodendrocytes",
        "d": "Schwann cells"
      },
      "correct_answer": "a",
      "explanation": "In AMAN, the complement along with IgG is deposited at the nodes of Ranvier of large motor \naxons. In AIDP, complement deposits along the outer surface of the Schwann cell.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Guillain-Barre Syndrome and Other Immune-mediat"
    },
    {
      "q_no": 7,
      "question": "Question 7: Which of the following features would you not expect to see in a patient with Guillian-Barre \nsyndrome?",
      "options": {
        "a": "Absent reflexes in lower limb",
        "b": "Ascending paralysis",
        "c": "Early bladder dysfunction",
        "d": "Bulbar paralysis"
      },
      "correct_answer": "c",
      "explanation": "Bladder dysfunction is not usually severe and does not appear early in the course of Guillain-Barre \nSyndrome(GBS). If bladder dysfunction is a prominent feature and comes early in the course, \ndiagnostic possibilities other than GBS should be considered. GBS is an acute demyelinating polyradiculoneuropathy. It is an autoimmune disorder triggered by \ninfections like: • Campylobacter jejuni • Cytomegalovirus (CMV) • Epstein Barr virus • Mycoplasma • Varicella zoster virus 1150 \nSold by @itachibot • Human immunodeficiency virus (HIV), dengue, or influenza It manifests as a rapidly evolving areflexic motor paralysis, with or without sensory disturbance. \nThe usual pattern is ascending paralysis. Proximal and distal muscles are equally involved. The \nlower cranial nerves are frequently affected, causing bulbar weakness.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Guillain-Barre Syndrome and Other Immune-mediat"
    },
    {
      "q_no": 8,
      "question": "Question 8: 1143 \nSold by @itachibot Which of the following sensory deficits is severely affected in a patient with Guillain-Barre \nsyndrome?",
      "options": {
        "a": "Pain",
        "b": "Temperature",
        "c": "Proprioception",
        "d": "Touch"
      },
      "correct_answer": "c",
      "explanation": "Loss of proprioception is severe in Guillain-Barre syndrome (GBS). GBS affects the large sensory fibers, leading to attenuation or loss of deep tendon reflexes and loss \nof proprioception. Cutaneous sensory deficits (e.g., loss of pain and temperature sensation) are usually relatively \nmild.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Guillain-Barre Syndrome and Other Immune-mediat"
    },
    {
      "q_no": 9,
      "question": "Question 9: A patient presents with complaints of lower extremity weakness. He initially noticed difficulty \nclimbing the stairs and now he is unable to stand. He gives a history of bloody diarrhea a few \nweeks ago. Which of the following parameters are expected to be elevated in the CSF of this \npatient?",
      "options": {
        "a": "Lymphocytes",
        "b": "Neutrophils",
        "c": "Opening pressure",
        "d": "Proteins"
      },
      "correct_answer": "d",
      "explanation": "The given scenario is suggestive of Guillain-Barre syndrome (GBS). Protein levels are elevated \n(100-1000mg/dl) in the CSF of a patient with this condition. The CSF cell counts are usually normal. Albuminocytologic dissociation, which is an elevation in \nCSF protein without an elevation in white blood cells, is characteristic in GBS. Causes of albuminocytologic dissociation are: • Guillain-Barre Syndrome • Spinal cord tumours",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Guillain-Barre Syndrome and Other Immune-mediat"
    },
    {
      "q_no": 10,
      "question": "Question 10: Which of the following conditions does not present with autonomic dysfunction?",
      "options": {
        "a": "Amyloidosis",
        "b": "Guillain-Barré syndrome",
        "c": "Botulism",
        "d": "Subclavian steal syndrome"
      },
      "correct_answer": "d",
      "explanation": "Subclavian steal syndrome does not present with autonomic dysfunction. Option A: Polyneuropathy is seen in sporadic and familial amyloidosis. In some cases, autonomic \ninsufficiency presents before distal painful polyneuropathy accompanied by sensory loss Option B: Guillain-Barré syndrome is associated with autonomic instability. This can present with \nBP fluctuations, arrhythmias, and GI disturbances. Option C: Botulinum toxin binds presynaptically to cholinergic nerve terminals. After uptake into \nthe cytoplasm, it blocks ACh release. Thus, patients with botulism present with motor paralysis \nand autonomic disturbances.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Guillain-Barre Syndrome and Other Immune-mediat"
    },
    {
      "q_no": 11,
      "question": "Question 11: A 23-year-old patient presents with rapidly progressing symmetric ascending paralysis since 2 \ndays. Nerve conduction studies are consistent with demyelination. He is found to have an \nelevated protein level in his CSF. Which of the following autonomic disturbance is likely to be \nseen in this patient?",
      "options": {
        "a": "Postural hypotension",
        "b": "Urinary incontinence",
        "c": "Diarrhea",
        "d": "Increased sweating"
      },
      "correct_answer": "a",
      "explanation": "1151 \nSold by @itachibot The given scenario is suggestive of Guillian-Barre syndrome (GBS). Postural hypotension is a \ncommon autonomic disturbance seen in this condition. Autonomic involvement is common and may occur even in patients whose GBS is otherwise mild. The usual autonomic manifestations are: • Loss of vasomotor control with wide fluctuation in blood pressure, postural hypotension • Cardiac dysrhythmias",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Guillain-Barre Syndrome and Other Immune-mediat"
    },
    {
      "q_no": 12,
      "question": "Question 12: The triad of Miller-Fisher syndrome includes all of the following, except:",
      "options": {
        "a": "Ataxia",
        "b": "Weakness",
        "c": "Areflexia",
        "d": "Ophthalmoplegia"
      },
      "correct_answer": "b",
      "explanation": "Weakness is not seen in the triad of Miller-Fisher syndrome (MFS). Miller Fisher syndrome is a variant of Guillain-Barré syndrome(GBS). Like Guillain-Barré \nsyndrome, symptoms may be preceded by a viral illness. It classically presents as a triad of: • Ataxia • Areflexia • Ophthalmoplegia The condition is usually not associated with weakness, and even if present, is very mild. It is \nstrongly associated with antibodies to the ganglioside GQ1b. The prognosis in Miller Fisher syndrome is usually good with recovery beginning within 2 to 4 \nweeks of the symptom onset, and completing by 6 months. Some individuals are left with residual \ndeficits. Relapses are rare. Treatment for Miller Fisher syndrome is identical to treatment for Guillain-Barré syndrome: \nintravenous immunoglobulin (IVIg) or plasmapheresis and supportive care.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Guillain-Barre Syndrome and Other Immune-mediat"
    },
    {
      "q_no": 13,
      "question": "Question 13: A patient presented to the ER with tingling, numbness, and weakness in all four limbs. She \nsays that the weakness started in the lower limbs and progressed to the upper limbs within a \nday. History is significant for a recent COVID-19 infection and surgery for cervical \nspondylosis and disc herniation 3 years ago. CT brain was normal and an MRI of the lumbar \nspine showed foraminal narrowing at L2-L3. CSF analysis showed increased protein levels. \nWhich of the following is recommended for the initial therapy of this patient?",
      "options": {
        "a": "Intrathecal steroids",
        "b": "Remdesivir",
        "c": "IV Immunoglobulin",
        "d": "Plasmapheresis"
      },
      "correct_answer": "c",
      "explanation": "The given scenario is suggestive of Guillain-Barre syndrome(GBS) probably as a result of \nCOVID-19. IV Immunoglobulin is the recommended initial therapy for patients with GBS. High-dose intravenous immune globulin (IVIg) and plasmapheresis are both equally effective in \nGBS and can be used as the initial therapy. However, IVIg is often the initial therapy chosen \nbecause of its ease of administration and good safety record. It is administered as five daily \ninfusions for a total dose of 2 g/kg body weight. Glucocorticoids have not been found to be \neffective in GBS.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Guillain-Barre Syndrome and Other Immune-mediat"
    },
    {
      "q_no": 14,
      "question": "Question 14: In a patient with Guillain-Barre syndrome, chronic inflammatory demyelinating \npolyneuropathy is suspected when",
      "options": {
        "a": "GBS deteriorates &gt;5 weeks after onset or relapses at least three times",
        "b": "GBS deteriorates &gt;5 weeks after onset or relapses at least two times",
        "c": "GBS deteriorates &gt;9 weeks after onset or relapses at least three times",
        "d": "GBS deteriorates &gt;8 weeks after onset or relapses at least two times"
      },
      "correct_answer": "c",
      "explanation": "Chronic inflammatory demyelinating polyneuropathy (CIDP) should be suspected when GBS \ndeteriorates &gt;9 weeks after onset or relapses at least three times. 1152 \nSold by @itachibot Onset is usually gradual over a few months or longer, but in a few cases, the initial attack is \nindistinguishable from that of GBS. CIDP is distinguished from GBS by its chronic course. In other respects, this neuropathy shares \nmany features with the common demyelinating form of GBS, including elevated CSF protein levels \nand the electrodiagnostic studies findings of acquired demyelination.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Guillain-Barre Syndrome and Other Immune-mediat"
    },
    {
      "q_no": 15,
      "question": "Question 15: 1145 \nSold by @itachibot Which of the following conditions are not associated with chronic inflammatory \ndemyelinating polyneuropathy?",
      "options": {
        "a": "Diabetic mellitus",
        "b": "Systemic lupus erythematosus",
        "c": "Lymphoma",
        "d": "Hepatitis A infection"
      },
      "correct_answer": "d",
      "explanation": "Hepatitis A infection is not associated with CIDP. Diseases associated with CIDP are: • Hepatitis B • Hepatitis C • Lymphoma • HIV • Diabetic mellitus • Systemic lupus erythematosus (SLE) • Pregnancy • Paraneoplastic syndrome • Inflammatory bowel disease • Amyloidosis",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Guillain-Barre Syndrome and Other Immune-mediat"
    },
    {
      "q_no": 16,
      "question": "Question 16: All are true about chronic inflammatory demyelinating polyneuropathy, except:",
      "options": {
        "a": "Symptoms present for &gt; 8 weeks duration",
        "b": "Relapse at least 3 times in a patient with Guillain-Barré syndrome",
        "c": "Symmetrical weakness",
        "d": "Small nerve fibers are affected more than large fibers"
      },
      "correct_answer": "d",
      "explanation": "Large nerve fibers are affected more than small fibers in CIDP. Difference between CIDP and Guillain-barré syndrome(GBS): GBS \nCIDP >8 weeks Duration \n<4 we \neks Affected Motor symptoms \nAffect \ned Sensory symptoms \nMild \nMore significantLargefiber > \nsmall fiber Affect \ned Autonomic nervous syst \nem Rare Antecedent event \nPrese \nnt Rare 1153 \nSold by @itachibot GBS \nCIDP Absent Deep tendon reflex \nAbsen \nt 2nd line of treatment Steroid \nNo ro \nle",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Guillain-Barre Syndrome and Other Immune-mediat"
    },
    {
      "q_no": 17,
      "question": "Question 17: A patient with chronic inflammatory demyelinating polyneuropathy is undergoing nerve \nconduction study. Which of the following findings is least likely to be seen in this patient?",
      "options": {
        "a": "Low amplitude",
        "b": "Decreased conduction velocity",
        "c": "Increased distal latency",
        "d": "Conduction block"
      },
      "correct_answer": "a",
      "explanation": "In CIDP, the amplitude is normal since the axons are intact. Nerve conduction study (NCS) in axonal injury and demyelinating diseases: Axonal injury \nDemyelination Amplitude \nDecreased \nNormal Distal latency \nNormal \nProlonged Conduction veloci \nty Normal \nSlow Conduction block \nAbsent \nPresent Absent \nPresent Temporal dispersi \non H wave \nNormal or abs \nent Prolonged or abse \nnt F wave \nNormal or abs \nent Prolonged or abse \nnt",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Guillain-Barre Syndrome and Other Immune-mediat"
    },
    {
      "q_no": 18,
      "question": "Question 18: In which of the following situations is nerve biopsy not indicated in patients with chronic \ninflammatory demyelinating polyneuropathy?",
      "options": {
        "a": "When the diagnosis not clear",
        "b": "When other causes of polyneuropathy cannot be ruled out",
        "c": "When electromyography shows axonal involvement",
        "d": "When there is no clinical or electrophysiological evidence of nerve functionality"
      },
      "correct_answer": "d",
      "explanation": "Nerve biopsy should not be done if there is no clinical or electrophysiological evidence of nerve \nfunctionality of that nerve in CIDP patients. This is because completely degenerated nerves \nusually convey limited information. In CIDP, nerve biopsy is indicated when: • Diagnosis is not clear • Other causes of polyneuropathy cannot be ruled out • Electromyography (EMG) shows axonal involvement",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Guillain-Barre Syndrome and Other Immune-mediat"
    },
    {
      "q_no": 19,
      "question": "Question 19: All of the following can be used for the treatment of a patient with chronic inflammatory \ndemyelinating polyneuropathy, except:",
      "options": {
        "a": "IV Immunoglobulin",
        "b": "Plasmapheresis",
        "c": "NSAIDs",
        "d": "Glucocorticoids"
      },
      "correct_answer": "c",
      "explanation": "NSAIDs are not used in the treatment of CIDP. 1154 \nSold by @itachibot The treatment of chronic inflammatory demyelinating polyneuropathy (CIDP) includes high-dose \nIV immunoglobulin, plasmapheresis, and glucocorticoids. Initial therapy is usually with IV immunoglobulin. If all the first-line agents fail, \nimmunosuppressants are attempted either alone or as an adjunctive treatment.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Guillain-Barre Syndrome and Other Immune-mediat"
    },
    {
      "q_no": 20,
      "question": "Question 20: A 63-year-old man presented with complaints of fatiguability and chronic back pain. On \nevaluation, he was found to have anemia and hypercalcemia. The X-ray of his skull is given \nbelow. Which of the following statements is true with regard to neuropathy seen in this \ncondition?",
      "options": {
        "a": "Polyneuropathy is seen in 50% of patients presenting with osteoporotic bone lesions",
        "b": "Polyneuropathy is seen in 5% of patients presenting with osteosclerotic features",
        "c": "The pattern is sensorimotor",
        "d": "Treatment may reverse severe neuropathy"
      },
      "correct_answer": "c",
      "explanation": "The given scenario is suggestive of multiple myeloma and the pattern of polyneuropathy seen in \nthis condition is sensorimotor type. Multiple myeloma-associated polyneuropathies occur in ~5% of patients with the commonly \nencountered type of multiple myeloma. Myeloma with osteosclerotic features, although representing only 3% of all myelomas, is \nassociated with polyneuropathy in one-half of cases. Polyneuropathy generally does not reverse even with successful suppression of the myeloma.",
      "image": "https://raw.githubusercontent.com/tk22kalal/mcqimage/main/mxmedicine/Guillain-Barre_Syndrome_and_Other_Immune-mediat_Q20_q.jpg",
      "explanation_image": null,
      "chapter_heading": "Guillain-Barre Syndrome and Other Immune-mediat"
    },
    {
      "q_no": 21,
      "question": "Question 21: 1147 \nSold by @itachibot What is the most common pattern of peripheral neuropathy in patients with polyarteritis \nnodosa?",
      "options": {
        "a": "T7 – T8",
        "b": "T8 – T9",
        "c": "T10 – T12",
        "d": "T6 – T7"
      },
      "correct_answer": "d",
      "explanation": "Most common pattern of peripheral neuropathy in polyarteritis nodosa (PAN) is mononeuritis \nmultiplex (multifocal motor-sensory neuropathy). It is asymmetric, due to ischemic lesions of \nnerve trunks and roots. Some cases present as a distal, symmetric sensorimotor polyneuropathy. Small- to medium-sized \narteries of the vasa nervorum, particularly the epineural vessels, are affected in PAN, resulting in \na widespread ischemic neuropathy. Combination therapy with glucocorticoids and rituximab is increasingly recommended as the \nstandard initial treatment, particularly for ANCA-associated vasculitis. 1155 \nSold by @itachibot Diseases of the Spinal Cord",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Guillain-Barre Syndrome and Other Immune-mediat"
    }
  ]
}
